Mark Morrison has been appointed Chief Commercial Officer at Helius Therapeutics – New Zealand’s largest licenced medicinal cannabis...

New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, is delighted to be working closely with Plant & Food...

By Dr Emma Stone for Helius Therapeutics Diverse cultures have long nurtured an understanding of cannabis as a form of pain relief....

Following the success of New Zealand’s first medicinal cannabis summit last year, organisers have confirmed MedCan 2021 will take place...

A randomised, double-blind, placebo-controlled clinical trial set out to determine the benefit of a tetrahydrocannabinol (THC)-rich...

In a statement today, the Medicinal Cannabis Agency has advised that transitional arrangements the country's Medicinal Cannabis Scheme...

On International Women's Day, we take look at two of the inspiring women who are striving to improve lives in New Zealand, and around the...

An updated Member's bill, to be put forward by Deputy Leader of the Opposition, Dr Shane Reti, proposes the introduction of a Medicinal...

Evidence suggests THCV, a minor cannabinoid found in the cannabis plant, may decrease appetite and up-regulate energy metabolism,...

Some women desperate for relief from the chronic pain of endometriosis have found using cannabis provides more effective relief from...

Mary Alice Simon has been appointed Chief Operating Officer (COO) at Helius Therapeutics, New Zealand’s largest licensed medicinal...

New Zealand’s largest licensed medicinal cannabis company, Helius Therapeutics, has appointed Mark Woods to its executive team as Chief...

New Zealand's leading medicinal cannabis firm, Helius Therapeutics has appointed Bruce Wallace as its Chief Quality Officer. Starting...

Helius Therapeutics has appointed Keryn Davies as its Quality Manager. She will ensure pharmaceutical and regulatory compliance, as well...